Lighter breast implants put to the test in 120 women
NCT ID NCT02777476
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study is testing B-Lite, a lighter breast implant, in 120 women who want breast augmentation for the first time. The implants are already approved in Europe and Israel. Researchers will measure changes in breast and bra size, and check for any problems. All surgeries follow standard procedures.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- B-Lite light weight breast implant (device)
- What this could lead to
- If successful, this could confirm that lighter breast implants are a safe and effective option for women seeking breast augmentation.
- What could go wrong
- This is a post-market study, not a randomized trial, so results may not apply to all patients. Implants carry risks like rupture or capsular contracture.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST IMPLANTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Akademikliniken
Stockholm, Sweden
-
ETHIANUM
Heidelberg, Germany
-
Herzelia Medical Center
Herzliya, Israel
More trials for these conditions
Other studies related to the condition(s) this trial covers.